Skip to main content
Top
Published in: Digestive Diseases and Sciences 3/2011

01-03-2011 | Original Article

High Prevalence of Heartburn and Low Acid Sensitivity in Patients with Idiopathic Achalasia

Authors: Julio Ponce, Vicente Ortiz, Nuria Maroto, Marta Ponce, Marco Bustamante, Vicente Garrigues

Published in: Digestive Diseases and Sciences | Issue 3/2011

Login to get access

Abstract

Background

Heartburn is frequently reported by patients with achalasia before treatment. However, the esophageal sensitivity to acid as a possible mediator of this symptom has not been previously evaluated.

Aim

To evaluate the prevalence of gastroesophageal reflux symptoms and the esophageal sensitivity to acid perfusion in patients with untreated achalasia.

Methods

Forty patients with achalasia were prospectively evaluated. Forty-three patients with gastroesophageal reflux disease comprised the control group (ten of them with Barrett’s esophagus). Symptoms were evaluated by a structured clinical questionnaire. Objective assessment was performed by ambulatory 24-h esophageal pH monitoring and endoscopy. Esophageal sensitivity to acid was evaluated by esophageal perfusion of ClH 0.1 N.

Results

Fifteen (37%) of the 40 patients with achalasia presented heartburn, but only four of them had esophagitis and/or abnormal esophageal pH recording. Eight patients had abnormal pH recording. Three patients had esophagitis. The esophagus was sensitive to acid in seven (17%) patients with achalasia, three of them with heartburn and one with abnormal pH recording. In the control group, 40 of 43 (93%) presented heartburn. Acid perfusion was positive in 32 (74%). Sensitivity to acid was lower in patients with achalasia than in those with gastroesophageal reflux disease with or without Barrett’s esophagus.

Conclusions

The prevalence of heartburn in patients with achalasia is high, although its association with objective indicators of gastroesophageal reflux disease is weak. Patients with achalasia have lower esophageal sensitivity to acid than patients with GERD, suggesting that heartburn is does not arise from this condition.
Literature
1.
go back to reference Bernstein LM, Baker LA. A clinical test for esophagitis. Gastroenterology. 1958;34:760–781.PubMed Bernstein LM, Baker LA. A clinical test for esophagitis. Gastroenterology. 1958;34:760–781.PubMed
2.
go back to reference Rosenzweig S, Traube M. The diagnosis and misdiagnosis of achalasia. A study of 25 consecutive patients. J Clin Gastroenterol. 1989;11(2):147–153.CrossRefPubMed Rosenzweig S, Traube M. The diagnosis and misdiagnosis of achalasia. A study of 25 consecutive patients. J Clin Gastroenterol. 1989;11(2):147–153.CrossRefPubMed
3.
go back to reference Spechler SJ, Souza RF, Rosenberg SJ, et al. Heartburn in patients with achalasia. Gut. 1995;37:305–308.CrossRefPubMed Spechler SJ, Souza RF, Rosenberg SJ, et al. Heartburn in patients with achalasia. Gut. 1995;37:305–308.CrossRefPubMed
4.
go back to reference Clouse RE, Diamant NE. Motor Physiology and motor disorders of the esophagus. In: Sleisenger MH, Fordtran JS, eds. Gastrointestinal and Liver Disease. Philadelphia: Saunders; 1998:467–490. Clouse RE, Diamant NE. Motor Physiology and motor disorders of the esophagus. In: Sleisenger MH, Fordtran JS, eds. Gastrointestinal and Liver Disease. Philadelphia: Saunders; 1998:467–490.
5.
go back to reference Blam ME, Delfyett W, Levine MS, et al. Achalasia: a disease of varied and subtle symptoms that do not correlate with radiographic findings. Am J Gastroenterol. 2002;8:1916–1923.CrossRef Blam ME, Delfyett W, Levine MS, et al. Achalasia: a disease of varied and subtle symptoms that do not correlate with radiographic findings. Am J Gastroenterol. 2002;8:1916–1923.CrossRef
6.
go back to reference Dent J, Brun J, Fendrick AM, et al. An evidence-based appraisal of reflux disease management—the Genval workshop report. Gut. 1999;44(suppl 2):S1–S16.CrossRef Dent J, Brun J, Fendrick AM, et al. An evidence-based appraisal of reflux disease management—the Genval workshop report. Gut. 1999;44(suppl 2):S1–S16.CrossRef
7.
go back to reference Ponce J, Garrigues V, Pertejo V, et al. Individual prediction of response to pneumatic dilation in patients with achalasia. Dig Dis Sci. 1996;41:2135–2141.CrossRefPubMed Ponce J, Garrigues V, Pertejo V, et al. Individual prediction of response to pneumatic dilation in patients with achalasia. Dig Dis Sci. 1996;41:2135–2141.CrossRefPubMed
8.
go back to reference Compte L, Garrigues V, Perpiñá M, et al. Prevalence of gastroesophageal reflux in asthma. J Asthma. 2000;37:175–182.CrossRefPubMed Compte L, Garrigues V, Perpiñá M, et al. Prevalence of gastroesophageal reflux in asthma. J Asthma. 2000;37:175–182.CrossRefPubMed
9.
go back to reference Garrigues V, Gisbert L, Bastida G, et al. Manifestations of gastroesophageal reflux and response to omeprazole therapy in patients with chronic posterior laryngitis: an evaluation based on clinical practice. Dig Dis Sci. 2005;11:2117–2123. Garrigues V, Gisbert L, Bastida G, et al. Manifestations of gastroesophageal reflux and response to omeprazole therapy in patients with chronic posterior laryngitis: an evaluation based on clinical practice. Dig Dis Sci. 2005;11:2117–2123.
10.
go back to reference Lundell LR, Dent J, Bennet JR, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut. 1999;45:172–180.CrossRefPubMed Lundell LR, Dent J, Bennet JR, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut. 1999;45:172–180.CrossRefPubMed
11.
go back to reference Vela MF, Vaezi MF. Cost-assessment of alternative management strategies for achalasia. Expert Opin Pharmacother. 2003;4:2019–2025.CrossRefPubMed Vela MF, Vaezi MF. Cost-assessment of alternative management strategies for achalasia. Expert Opin Pharmacother. 2003;4:2019–2025.CrossRefPubMed
12.
go back to reference Jung B, Steinbach J, Beaumont Ch, et al. Lack of association between esophageal acid sensitivity detected by prolonged pH monitoring and Bernstein testing. Am J Gastroenterol. 2004;99:416–418.CrossRef Jung B, Steinbach J, Beaumont Ch, et al. Lack of association between esophageal acid sensitivity detected by prolonged pH monitoring and Bernstein testing. Am J Gastroenterol. 2004;99:416–418.CrossRef
13.
go back to reference Howard PJ, Maher L, Pryde A, et al. Symptomatic gastro-oesophageal reflux, abnormal oesophageal acid exposure, and mucosal acid sensitivity are three separate, though related, aspects of gastro-oesophageal reflux disease. Gut. 1991;32:128–132.CrossRefPubMed Howard PJ, Maher L, Pryde A, et al. Symptomatic gastro-oesophageal reflux, abnormal oesophageal acid exposure, and mucosal acid sensitivity are three separate, though related, aspects of gastro-oesophageal reflux disease. Gut. 1991;32:128–132.CrossRefPubMed
14.
go back to reference Jonson DA, Winters C, Spurling TJ, et al. Esophageal acid sensitivity in Barrett’s esophagus. J Clin Gastroenterol. 1987;9:23–27.CrossRef Jonson DA, Winters C, Spurling TJ, et al. Esophageal acid sensitivity in Barrett’s esophagus. J Clin Gastroenterol. 1987;9:23–27.CrossRef
15.
go back to reference Smart HL, Foster PN, Evans DF, et al. Twenty-four hour oesophageal acidity in achalasia before and after pneumatic dilatation. Gut. 1987;28:883–887.CrossRefPubMed Smart HL, Foster PN, Evans DF, et al. Twenty-four hour oesophageal acidity in achalasia before and after pneumatic dilatation. Gut. 1987;28:883–887.CrossRefPubMed
16.
go back to reference Katz PO, Richter JE, Cowan R, et al. Apparent complete lower esophageal sphincter relaxation in achalasia. Gastroenterology. 1986;90:978–983.PubMed Katz PO, Richter JE, Cowan R, et al. Apparent complete lower esophageal sphincter relaxation in achalasia. Gastroenterology. 1986;90:978–983.PubMed
17.
go back to reference Garrigues V, Ponce J, Pertejo V, et al. J. Acalasia esofágica con relajación aparentemente normal del esfínter esofágico inferior: significado clínico y respuesta terapéutica a la dilatación neumática. Rev Esp Enferm Dig. 1996;88:529–532. Garrigues V, Ponce J, Pertejo V, et al. J. Acalasia esofágica con relajación aparentemente normal del esfínter esofágico inferior: significado clínico y respuesta terapéutica a la dilatación neumática. Rev Esp Enferm Dig. 1996;88:529–532.
18.
go back to reference Mearin F, Malagelada JR. Complete lower oesophageal sphincter relaxation observed in some achalasia patients is functionally inadequate. Am J Physiol Gastrointest Liver Physiol. 2000;278:G376–G383.PubMed Mearin F, Malagelada JR. Complete lower oesophageal sphincter relaxation observed in some achalasia patients is functionally inadequate. Am J Physiol Gastrointest Liver Physiol. 2000;278:G376–G383.PubMed
20.
go back to reference Jeckinson AD, Scott SM, Yazaki E, et al. Compliance measurement of lower esophageal sphincter and esophageal body in achalasia and gastroesophageal reflux disease. Dig Dis Sci. 2001;46:1937–1942.CrossRef Jeckinson AD, Scott SM, Yazaki E, et al. Compliance measurement of lower esophageal sphincter and esophageal body in achalasia and gastroesophageal reflux disease. Dig Dis Sci. 2001;46:1937–1942.CrossRef
Metadata
Title
High Prevalence of Heartburn and Low Acid Sensitivity in Patients with Idiopathic Achalasia
Authors
Julio Ponce
Vicente Ortiz
Nuria Maroto
Marta Ponce
Marco Bustamante
Vicente Garrigues
Publication date
01-03-2011
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 3/2011
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-010-1343-x

Other articles of this Issue 3/2011

Digestive Diseases and Sciences 3/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine